サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722933

下肢静脈瘤治療の市場規模、シェア、動向、予測：製品、手技、エンドユーザー、地域別、2025年～2033年

Varicose Vein Treatment Market Size, Share, Trends and Forecast by Product, Procedure, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
下肢静脈瘤治療の市場規模、シェア、動向、予測：製品、手技、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

下肢静脈瘤治療の世界市場規模は、2024年に4億5,880万米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに6億9,690万米ドルに達し、2025年から2033年にかけて4.52％のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは47.8%を超えています。高齢者人口の増加、低侵襲（MI）手技の技術的進歩、認知度の向上とヘルスケア支出の増加、治療の選択肢と地理的範囲を拡大するための技術革新と戦略的提携に注力する主要企業が市場成長を促す要因の一部です。

下肢静脈瘤治療の市場分析：

主な市場促進要因：高齢化社会における静脈瘤の有病率の上昇と治療技術の進歩により、市場は緩やかな成長を遂げています。

主要市場動向：従来の外科的治療法に比べ、その有効性、痛みの軽減、回復期間の短さから、侵襲性の低い治療法へのシフトが進んでいます。これに加えて、静脈瘤治療における画像技術の統合が進み、治療の精度と治療成績が向上していることも、市場の成長に寄与しています。

地理的動向：北米は、高いヘルスケア支出、高度な医療インフラ、および大衆の静脈瘤状態に対する意識の高まりによって市場を独占しています。

競合情勢：下肢静脈瘤治療の業界の主な市場プレイヤーには、Alma Lasers Ltd.（Sisram Medical Ltd.）、Alma Laser Ltd.（Sisram Medical Ltd.）、Alma Lasers Ltd.（Sisram Medical Ltd.）、Alma Lasers Ltd.（Sisram Medical Ltd.）などがいます。（Sisram Medical Ltd.）、Angiodynamics Inc.、Biolitec AG（BioMed Technology Holdings Ltd.）、Boston Scientific Corporation、Eufoton S.R.L.、Fotona、Medtronic plc、Sciton Inc.、Teleflex Incorporated、The Vein Company、VVT Medical Ltd.、WON TECH Co.Ltd.などがあります。

課題と機会：先進的な静脈瘤治療の費用が増加しており、特に後進地域では十分な保険が適用されない患者にとっては高額となる可能性があり、市場収益に影響を及ぼしています。とはいえ、このことは業界参加者にとって、より多くの人々が治療を受けられるように手頃な価格のソリューションを開発するチャンスでもあります。さらに、健康についての知識を深めることで、潜在的な患者に様々な治療選択肢を伝え、潜在的な顧客層を広げることが、最近の下肢静脈瘤治療の市場の主要な動向の1つとなっています。

下肢静脈瘤治療の市場の動向：

治療における技術の進歩

静脈内レーザー治療（EVLT）、ラジオ波焼灼療法（RFA）、超音波ガイド下硬化療法などの現在進行中の進歩は、侵襲的な手術から低侵襲（MI）かつ非外科的な選択肢へと治療アプローチを変えつつあります。患者にとって、このような新技術は回復の早さ、痛みの軽減、術後合併症の可能性の低減を約束するものであり、このことが手術の人気を高めています。2023年、世界の低侵襲手術市場規模は529億米ドルでした。IMARC Groupのレポートによると、この市場は2032年までに910億米ドルに達し、2024年から2032年の間に6％のCAGRを示すと予想されています。悪化した静脈をよりピンポイントで治療するためのイメージング技術と組み合わせたレーザーや高周波デバイスのさらなる開発が、下肢静脈瘤治療の需要を牽引しています。企業収益は研究開発（R&D）に振り向けられ、既存の技術を最大限に活用し、新たなイノベーションを生み出しています。

ヘルスケアの世界化

国際的な提携により、ヘルスケア専門家はベストプラクティスや技術を交換し、世界的に治療の質を高めています。例えば、VVT Medicalは、2023年6月のFDA承認後、米国でScleroSafeプラットフォームを販売するため、Methapharmとの戦略的販売契約を発表しました。この提携は、Methapharmの静脈瘤に関する専門知識を活用するもので、ScleroSafeの革新的な非加熱・非血管拡張手技による治療の変革を目指しています。このような世界の交流は、先進的な治療技術をさまざまな地域で、治療の質の標準化とともに利用できることを保証し、下肢静脈瘤治療の市場の成長を支えています。また、医療ツーリズムも一因となっており、患者は一流の治療をより手頃な価格で求めて海外に渡航しています。2023年、世界の医療ツーリズム産業は1,197億米ドルと評価されました。IMARCグループは、市場は2024年から2032年にかけてCAGR20.1％で拡大し、2032年には6,508億米ドルに達すると予測しています。グローバリゼーションは、世界の静脈瘤治療へのアクセスの向上と質の向上をもたらし、市場の拡大と技術の進歩を支えています。

規制当局の承認とサポート

下肢静脈瘤治療の開発を進めるためには、規制当局の承認とサポートを得ることが不可欠です。規制機関は新しい医療機器や治療に対して厳しい基準を設け、明確な承認手続きを提供しています。厳しい規制状況は、イノベーションを推進するための研究や臨床試験への投資を企業に動機付ける。当局による治療の承認は、ヘルスケア提供者と患者の間に信頼と信用を築き、市場における安全で効率的な選択肢の存在を保証します。さらに、強固な規制は最先端の治療法の市場参入を加速させ、その普及を早め、下肢静脈瘤治療の最新の選択肢の幅を広げることができます。2024年4月、VVT Medicalは韓国食品医薬品安全部からScleroSafe（TM）を承認され、韓国市場で大きなマイルストーンを達成しました。これは、FDAの510（k）クリアランスとCEマークを取得した後であり、ScleroSafe（TM）が下肢静脈瘤治療の信頼できる選択肢であることが確認されました。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の下肢静脈瘤治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • アブレーションデバイス
    • 主要セグメント
      • 高周波アブレーション装置
      • レーザーアブレーション装置
      • その他
  • 硬化療法注射
  • その他

第7章 市場内訳：手技別

  • 注射硬化療法
  • 静脈内アブレーション
  • 外科的結紮術とストリッピング術

第8章 市場内訳：エンドユーザー別

  • 病院
  • クリニック
  • 外来センター

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Alma Lasers Ltd.（Sisram Medical Ltd.）
    • Angiodynamics Inc.
    • Biolitec AG（BioMed Technology Holdings Ltd.）
    • Boston Scientific Corporation
    • Eufoton S.R.L.
    • Fotona
    • Medtronic plc
    • Sciton Inc.
    • Teleflex Incorporated
    • The Vein Company
    • VVT Medical Ltd.
    • WON TECH Co. Ltd
図表

List of Figures

  • Figure 1: Global: Varicose Vein Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Varicose Vein Treatment Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Varicose Vein Treatment Market: Breakup by Procedure (in %), 2024
  • Figure 6: Global: Varicose Vein Treatment Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Varicose Vein Treatment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Varicose Vein Treatment (Ablation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Varicose Vein Treatment (Ablation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Varicose Vein Treatment (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Varicose Vein Treatment (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Varicose Vein Treatment (Endovenous Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Varicose Vein Treatment (Endovenous Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Varicose Vein Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Varicose Vein Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Varicose Vein Treatment (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Varicose Vein Treatment (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Varicose Vein Treatment (Ambulatory Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Varicose Vein Treatment (Ambulatory Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Varicose Vein Treatment Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Varicose Vein Treatment Industry: SWOT Analysis
  • Figure 76: Global: Varicose Vein Treatment Industry: Value Chain Analysis
  • Figure 77: Global: Varicose Vein Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Varicose Vein Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Varicose Vein Treatment Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Varicose Vein Treatment Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 4: Global: Varicose Vein Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Varicose Vein Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Varicose Vein Treatment Market: Competitive Structure
  • Table 7: Global: Varicose Vein Treatment Market: Key Players
目次
Product Code: SR112025A5494

The global varicose vein treatment market size was valued at USD 458.8 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 696.9 Million by 2033, exhibiting a CAGR of 4.52% from 2025-2033. North America currently dominates the market, holding a market share of over 47.8% in 2024. The growing elderly population, technological advancements in minimally invasive (MI) procedures, increasing awareness and healthcare spending, and key players focusing on innovation and strategic collaborations to expand treatment options and geographic reach are some of the factors impelling the market growth.

Varicose Vein Treatment Market Analysis:

Major Market Drivers: The market is experiencing moderate growth because of the rising prevalence of varicose veins among the aging population and advancements in treatment technologies.

Key Market Trends: There is a shift towards less invasive treatment methods because of their efficacy, reduced pain, and shorter recovery periods compared to traditional surgical methods. Besides this, the growing integration of imaging technologies in varicose vein treatments, which enhances the precision of treatments and outcomes, is contributing to the growth of the market.

Geographical Trends: North America dominates the market, driven by high healthcare expenditure, advanced medical infrastructure, and increasing awareness about varicose vein conditions among the masses.

Competitive Landscape: Some of the major market players in the varicose vein treatment industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd., among many others.

Challenges and Opportunities: The growing cost of advanced varicose vein treatments, which can be prohibitive for patients without adequate insurance coverage, particularly in less developed regions, is influencing the market revenue. Nevertheless, this also creates a chance for industry participants to develop affordable solutions that can increase the availability of treatments to a wider range of people. Moreover, gaining more knowledge about health presents one of the major varicose vein treatment market recent developments to inform potential patients about the various treatment options, broadening the potential customer base.

Varicose Vein Treatment Market Trends:

Technological Advancements in Treatment

Ongoing advancements like endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and ultrasound-guided sclerotherapy are changing treatment approaches from invasive surgeries to minimally invasive (MI) and non-surgical options. For patients, such new technologies promise quicker recovery, less pain, and smaller chances of post-operation complications, which is causing the popularity of the surgeries to grow. In 2023, the size of the global minimally invasive surgery market was US$ 52.9 Billion. As per the report by the IMARC Group, the market is expected to reach US$ 91.0 Billion by 2032, exhibiting a CAGR of 6% during 2024-2032. Further development of lasers and radiofrequency devices in combination with imaging technologies for more pinpoint treatment in the ailing veins is driving the varicose vein treatment demand. Companies are channelizing their revenues for research and development (R&D) to make the best use of technologies existing and to come up with new innovations.

Globalization of Healthcare

By partnering internationally, healthcare professionals exchange best practices and technologies, enhancing the quality of treatment globally. For instance, VVT Medical announced a strategic distribution agreement with Methapharm to market its ScleroSafe platform in the USA, following FDA approval in June 2023. This collaboration leverages Methapharm's expertise in varicose veins, aiming to transform treatment with ScleroSafe's innovative, non-thermal, non-tumescent technique. This worldwide exchange guarantees that advanced treatment techniques are available in different areas with standardization of care quality, supporting the varicose vein treatment market growth. Medical tourism is also a factor, with patients traveling overseas in search of top-notch treatments at more affordable prices. In 2023, the medical tourism industry in the world was valued at US$119.7 billion. The IMARC Group estimates the market would expand at a CAGR of 20.1% from 2024 to 2032, reaching US$ 650.8 billion in 2032. Globalization leads to increased accessibility and improved quality of varicose vein treatments worldwide, supporting market expansion and technological progress.

Regulatory Approvals and Support

Obtaining regulatory approvals and support is essential for advancing the development of varicose vein treatment. Regulatory agencies establish stringent criteria and provide clear approval procedures for new medical devices and treatments. The strict regulatory landscape motivates companies to invest in research and clinical trials to drive innovation. The approval of treatments by authorities builds trust and confidence between healthcare providers and patients, guaranteeing the presence of secure and efficient choices in the market. Furthermore, robust regulations can accelerate the entry of cutting-edge treatments into the market, quickening their adoption and expanding the range of modern options for varicose vein treatment. In April 2024, VVT Medical achieved a major milestone in the Korean market with the approval of its ScleroSafe(TM) device by the Korean Ministry of Food and Drug Safety. This was after the FDA 510(k) clearance and CE Mark, confirming ScleroSafe(TM) as a dependable option for varicose vein treatment.

Varicose Vein Treatment Market Segmentation:

Breakup by Product:

  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Laser Ablation Devices
  • Others
  • Sclerotherapy Injection
  • Others

Ablation devices are an important segment, especially radiofrequency and laser ablation devices, because they are preferred in the treatment of varicose veins. These are effective in shutting off problematic veins with ways that are less invasive than those used hitherto, thereby inflicting less pain and delivering the patient to recovery quickly. Radiofrequency ablation devices utilize thermal energy to heat and collapse the vein, while laser ablation uses light energy to accomplish similar outcomes, providing effective options for patients who prefer less invasive treatments. In 2023, the market size of ablation devices worldwide reached US$ 5.9 billion. IMARC Group forecasts that the market will reach a value of US$ 14.4 billion by 2032, showing a 10.2% CAGR from 2024 to 2032.

Sclerotherapy injections have a solid presence in the industry, thereby influencing the varicose vein treatment market revenue. This technique includes injecting a solution into the varicose veins, which results in scarring and redirecting blood to healthier veins, ultimately causing the treated vein to vanish. The technique is used because of its effectiveness in addressing minor varicose veins and spider veins, its ease of use, and its reasonable cost. It is particularly popular in outpatient settings, where fast recovery is an important factor.

Others encompass a range of additional options, such as compression stockings and surgical procedures. Compression stockings are often utilized as a non-surgical method to control symptoms and delay the advancement of varicose veins, especially in the initial phases or mild instances. Surgical procedures, while less frequently used now because of the increase in minimally invasive (MI) techniques, are still utilized in serious situations when other treatments do not work. This part serves a wide range of patients, providing options from basic preventive care to extensive surgical treatments.

Breakup by Procedure:

  • Injection Sclerotherapy
  • Endovenous Ablation
  • Surgical Ligation and Stripping

Injection sclerotherapy holds the largest share of the industry

Injection sclerotherapy is the most dominant sector in the varicose vein treatment industry, mainly because of its effectiveness, low level of invasiveness, and cost-effectiveness. The process includes injecting a sclerosant solution into the varicose veins to irritate the vein walls, leading them to collapse and bond. As time passes, the vein that has been treated fades away as it gets absorbed back into the surrounding tissue. The popularity of sclerotherapy is enhanced by its ability to be performed in outpatient settings, its quick resolution of cosmetic concerns and discomfort from small varicose and spider veins, and its short recovery time, making it a preferred option for patients wanting both effectiveness and convenience. In 2023, the sclerotherapy market in the world was valued at US$ 1.2 billion. The IMARC Group projects that the market will expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, when it reaches US$ 2.0 billion in 2032.

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Centers

Hospitals represents the leading market segment

Hospitals dominate the market due to their extensive treatment options and ability to manage complicated cases that require advanced medical interventions, shaping a positive varicose vein treatment market outlook. They have the required infrastructure to offer various types of treatments for varicose veins, including less invasive procedures like sclerotherapy and endovenous ablation and more aggressive techniques such as surgical ligation and stripping. This section benefits a strong level of confidence from patients who are looking for dependable and efficient treatments from specialized vascular surgeons and interventional radiologists. Moreover, hospitals play a key role in are frequently the top choice for patients with advanced varicose veins who may need comprehensive care from various healthcare providers and extended monitoring, solidifying their position in the market.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest varicose vein treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for varicose vein treatment.

North America holds biggest share in the market, mainly due to substantial healthcare expenditure, cutting-edge medical technologies, and a solid healthcare system. This area, encompassing both the United States and Canada, shows a high need for minimally invasive (MI) procedures because of a high number of varicose veins in its elderly residents. As per the 2023 US Census Bureau report, the number of people in the US aged 65 and above was projected to increase by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, it is expected that the percentage of people in this age range in the overall population will rise from 17% to 23%. Furthermore, North America is advantaged by having top healthcare firms and a strong regulatory framework that encourages quick uptake of new technologies. The strong presence of the region in the global market is also influenced by its extensive insurance coverage and high level of patient consciousness.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.

Key Questions Answered in This Report

  • 1.What is varicose vein treatment?
  • 2.How big is the varicose vein treatment market?
  • 3.What is the expected growth rate of the global varicose vein treatment market during 2025-2033?
  • 4.What are the key factors driving the global varicose vein treatment market?
  • 5.What is the leading segment of the global varicose vein treatment market based on procedure?
  • 6.What is the leading segment of the global varicose vein treatment market based on end user?
  • 7.What are the key regions in the global varicose vein treatment market?
  • 8.Who are the key players/companies in the global varicose vein treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Varicose Vein Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Ablation Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Radiofrequency Ablation Devices
      • 6.1.2.2 Laser Ablation Devices
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Sclerotherapy Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Injection Sclerotherapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Endovenous Ablation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Surgical Ligation and Stripping
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Angiodynamics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biolitec AG (BioMed Technology Holdings Ltd.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eufoton S.R.L.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Fotona
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sciton Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teleflex Incorporated
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Vein Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 VVT Medical Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 WON TECH Co. Ltd
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials